WallStSmart
ALT

Altimmune Inc

NASDAQ: ALT · HEALTHCARE · BIOTECHNOLOGY

$2.60
-1.14% today

Updated 2026-04-30

Market cap
$511.15M
P/E ratio
P/S ratio
12,467.17x
EPS (TTM)
$-1.00
Dividend yield
52W range
$3 – $8
Volume
4.1M

Altimmune Inc (ALT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$1.53M$-13.64M$-13.20M$-28.15M$-14.86M$-7.81M$-2.32M$-7.17M$-8.47M$-3.22M$201.51M$-20.21M$-9.39M$-9.60M$-34.44M$-78.24M$-62.59M$-75.81M$-79.85M$-67.53M
Capital expenditures$0.00$882345.00$509315.00$1.03M$374581.00$71439.00$0.00$84579.00$92269.00$86507.00$30687.00$166327.00$1.02M$28999.00$342421.00$12.31M$126000.00$47000.00$0.00$11000.00
Depreciation
Stock-based comp$3.04M$3.44M$2.51M$2.57M$1.89M$1.36M$1.66M$613017.00$2.24M$1.44M$773248.00$1.26M$2.58M$5.52M$8.10M$10.64M$14.39M$16.08M
Free cash flow$1.53M$-14.52M$-13.71M$-29.18M$-15.24M$-7.88M$-2.32M$-7.25M$-8.57M$-3.30M$201.48M$-20.38M$-10.40M$-9.63M$-34.78M$-90.55M$-62.71M$-75.86M$-79.85M$-67.55M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$22898.00$3.79B$135.47M
Share repurchases
Debt repayment
Net change in cash$-548556.00$1.46M$-2.22M$8.16M$-3.07M$138.43M$9.35M$22.10M$-25.36M$106.96M$74.38M